• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference

    2/18/25 4:01:00 PM ET
    $ADGM
    Medical/Dental Instruments
    Health Care
    Get the next $ADGM alert in real time by email

    Adagio Medical Holdings, Inc. (NASDAQ:ADGM, the "Company")), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced that management will be attending TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025, at the Marriott Copley Place in Boston, MA.

    About Adagio Medical

    Adagio Medical is an early commercial stage medical device company located in Laguna Hills, California focusing on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250218327066/en/

    Media:

    Ilya Grigorov

    Vice President, Global Marketing and Product Management of Adagio Medical, Inc.

    [email protected]



    Investor:

    [email protected]

    Get the next $ADGM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADGM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ADGM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider George Dan

      3 - Adagio Medical Holdings, Inc. (0002006986) (Issuer)

      4/28/25 5:23:28 PM ET
      $ADGM
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Director Cox James L

      4 - Adagio Medical Holdings, Inc. (0002006986) (Issuer)

      3/21/25 7:00:18 PM ET
      $ADGM
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Director Gardiner Sandra A.

      4 - Adagio Medical Holdings, Inc. (0002006986) (Issuer)

      3/21/25 6:59:40 PM ET
      $ADGM
      Medical/Dental Instruments
      Health Care

    $ADGM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Adagio Medical Reports First Quarter 2025 Results

      Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the first quarter ended March 31, 2025. Recent Business Highlights: Received Breakthrough Device Designation from the U.S. Food and Drug Administration (the "FDA") for the vCLAS™ Cryoablation System ("vCLAS"), for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia ("VT") in patients with ischemic or non-ischemic structural heart disease. The vCLASTM Cryoablation System is currently the subject of the FULCRUM-VT Investigational Device Exemption (

      5/15/25 4:05:00 PM ET
      $ADGM
      Medical/Dental Instruments
      Health Care
    • Adagio Medical to Present at the BofA Securities 2025 Health Care Conference

      Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the BofA Securities Health Care Conference on Tuesday, May 13, 2025, at 9:20 a.m. PT at the Encore Hotel in Las Vegas, NV. Presentation Information A live and recorded webcast of the presentation will be available at: https://bofa.veracast.com/webcasts/bofa/healthcare2025/id5FQ7Pq.cfm About Adagio Medical Adagio Medical is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietar

      5/7/25 8:30:00 AM ET
      $ADGM
      Medical/Dental Instruments
      Health Care
    • Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

      Agency's Breakthrough Device Designation Program Allows for Priority Review of Ablation Technology for Ventricular Tachycardia Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has received Breakthrough Device designation from the U.S. Food and Drug Administration ("FDA") for its vCLASTM Cryoablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia ("VT") in patients with ischemic or non-ischemic structural heart disease. Adagio's vCLASTM Cryoablation System, which is currently the subject of an I

      4/17/25 8:30:00 AM ET
      $ADGM
      Medical/Dental Instruments
      Health Care

    $ADGM
    SEC Filings

    See more
    • SEC Form 424B3 filed by Adagio Medical Holdings Inc

      424B3 - Adagio Medical Holdings, Inc. (0002006986) (Filer)

      5/15/25 4:58:47 PM ET
      $ADGM
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by Adagio Medical Holdings Inc

      424B3 - Adagio Medical Holdings, Inc. (0002006986) (Filer)

      5/15/25 4:58:30 PM ET
      $ADGM
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Adagio Medical Holdings Inc

      SCHEDULE 13G/A - Adagio Medical Holdings, Inc. (0002006986) (Subject)

      5/15/25 4:48:19 PM ET
      $ADGM
      Medical/Dental Instruments
      Health Care

    $ADGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Adagio Medical Holdings Inc

      SC 13G - Adagio Medical Holdings, Inc. (0002006986) (Subject)

      11/13/24 4:30:17 PM ET
      $ADGM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Adagio Medical Holdings Inc

      SC 13G - Adagio Medical Holdings, Inc. (0002006986) (Subject)

      8/12/24 4:22:57 PM ET
      $ADGM
      Medical/Dental Instruments
      Health Care